Results 181 to 190 of about 1,754,511 (314)

Work health and safety and return to work management Education Standards Board

Work health and safety and return to work management at Education Standards Board, including: workplace injury claims, work health and safety regulation and return to work costs\r\

core  

James H. Burrows

, 1999
James H. Burrows Inducted: 1999 Citation: For leadership of the Institute for Computer Sciences and Technology as NBS/NIST responded to national needs for measurements and standards for information technologies.
National Institute of Standards and Technology; National Institute of Standards and Technology
core  

Derivation and Definitions of Clinical Study Variables for Multiple Long Term Conditions in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Modified Delphi Methods and Consensus Study on Behalf of the International Cardiovascular and Respiratory Alliance

Pragmatic and Observational Research
Tobin Joseph,1– 3 Mohit Bhutani,4 Amy Couper,5,6 Rachel Pullen,5 Ramesh Nadarajah,1– 3 Luis Alves,7,8 Maria Felicia Montero-Arias,9,10 Riyad Al-Lehebi,11,12 David D Berg,13 Nathaniel M Hawkins,14 John R Hurst,15 Christine R Jenkins,16,17 Alan Kaplan,5,18,
Joseph T, Bhutani M, Couper A, Pullen R, Nadarajah R, Alves L, Montero-Arias MF, Al-Lehebi R, Berg DD, Hawkins NM, Hurst JR, Jenkins CR, Kaplan A, Kocks JWH, Kostikas K, Lam CSP, Lapperre TS, Rhee CK, Sattar N, Stolz D, Tse G, Winders T, Price D, Gale CP   +23 more
doaj  

Data standards for single-cell RNA-sequencing of paediatric cancer. [PDF]

Clin Transl Immunology
Xu X, Saxon J, Soon MSF, Lee CY, Tuong ZK.   +4 more
europepmc   +1 more source

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

Molecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann, Eduardo García‐Galea, Alice O'Farrell, Zak Kinsella, Maxime Meylan, Florent Petitprez, Ingrid Arijs, Tom Venken, Hari Ps, Adrian Lärkeryd, Ian Miller, Janick Selves, Nadja Meindl‐Beinker, Fiorella Ruiz‐Pace, Elena Élez, Raquel Comas‐Navarro, Frank Lincoln, Dirk Fey, Gift Nyamundanda, Aoife Nolan, Joern Lewin, Raquel Perez‐Lopez, Jonathan Briody, Kathleen Bennett, Walter Kolch, David Matallanas, Alexander Kel, Enrique Arenas, Joaquín Arribas, Bart Ghesquière, Josep Tabernero, Julie Meilleroux, Deborah McNamara, Ray McDermott, Marvin Lim, Mary O'Reilly, Brian Bird, Lisa Stack, Lucia Moloney, Patrick Morris, Keith Egan, Maciej Milewski, Lars Scheuer, Joachim Behringer, Georg Bolz, Ramon Salazar, Cristina Santos, Andrea Ruiz, Orla Casey, Verena Murphy, Matthias Ebert, Livio Trusolino, Diether Lambrechts, Anguraj Sadanandam, Catherine Sautès‐Fridman, Jochen Prehn, Paolo Nuciforo, Jacques Fieschi, Florence Monville, Darran O'Connor, Wolf Fridman, Annette Byrne   +61 more
wiley   +1 more source

What Have Data Standards Ever Done for Us? [PDF]

Mol Cell Proteomics
Orchard SE.
europepmc   +1 more source

Fast-Tracking Health Data Standards Development and Adoption in Real-World Settings: A Pilot Approach. [PDF]

Appl Clin Inform, 2021
Dennis AF, White PJ, Zayas-Cabán T.
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Charles P. Saylor

, 1988
CHARLES P. SAYLOR NBS: 1931 ‑ 1968 Birth: June 14, 1901, Camden, New Jersey Death: April 27, 1982, Silver Spring, Maryland Education: Cornell University degrees in chemistry: BS, 1923; PhD, 1928 Principal fields: Physical chemistry and chemical ...
National Institute of Standards and Technology
core  

Paediatric-specific content in data standards for health. [PDF]

Arch Dis Child
Turner MA, Kalra D, Cornet R, Palmeri A, Sen A, Owen J, Pansieri C, Lee J, Hedley V, Nally S, Bonifazi F, Leary R, Straub V.   +12 more
europepmc   +1 more source